|
Characteristics
| |
FAS (n = 35)
|
Safety/surgery set (n = 32)
|
|---|
|
Age (years), median (range)
| |
62 (35, 73)
|
60 (35, 73)
|
|
Gender, n (%)
|
Male
|
27 (77.1%)
|
26 (81.2%)
|
|
Female
|
8 (22.9%)
|
6 (18.8%)
|
|
ECOG PS, n (%)
|
0–1
|
35 (100%)
|
32 (100%)
|
|
Tumor location, n (%)
|
Stomach
|
24 (68.6%)
|
21 (65.6%)
|
|
GEJ
|
11 (31.4%)
|
11 (34.4%)
|
|
Histology, n (%)
|
Differentiated type
|
11 (31.4%)
|
10 (31.2%)
|
|
Undifferentiated type
|
22 (62.9%)
|
21 (65.6%)
|
|
NOS
|
2 (5.7%)
|
1 (3.1%)
|
|
Lauren subtype, n (%)
|
Intestinal
|
18 (51.4%)
|
17 (53.1%)
|
|
Mixed
|
4 (11.4%)
|
4 (12.5%)
|
|
Diffuse
|
8 (22.9%)
|
8 (25.0%)
|
|
Unknown
|
5 (14.3%)
|
3 (9.4%)
|
|
Clinical tumor stage, n (%)
|
cT3
|
8 (22.9%)
|
8 (25.0%)
|
|
cT4a
|
27 (77.1%)
|
24 (75.0%)
|
|
Clinical node stage, n (%)
|
cN1
|
11 (31.4%)
|
11 (34.4%)
|
|
cN2
|
21 (60.0%)
|
20 (62.5%)
|
|
cN3
|
3 (8.6%)
|
1 (3.1%)
|
- FAS full analysis set, ECOG PS Eastern Cooperative Oncology Group performance status, GEJ gastroesophageal junction, NOS not otherwise specified
